Rivaroxaban Monotherapy for Atrial Fibrillation and Coronary Artery Disease in Underweight/Obese Patients: Evidence Is Needed

[Figure: see text]

Detalles Bibliográficos
Autores principales: Zhou, Dao, Fan, Jiaqi, Liu, Xianbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877208/
https://www.ncbi.nlm.nih.gov/pubmed/36713757
http://dx.doi.org/10.1016/j.jacasi.2022.09.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877208/
https://www.ncbi.nlm.nih.gov/pubmed/36713757
http://dx.doi.org/10.1016/j.jacasi.2022.09.008

Ejemplares similares